Introduction {#s1}
============

Approximately 2--3% of Americans suffer from OCD, a mental illness characterized by chronic intrusive thoughts (obsessions) and/or repetitive behaviors (compulsions). Half of these patients experience severe disease that seriously impairs their occupational, academic, and/or interpersonal functioning (Kessler et al., [@B83]). Although behavioral therapy and medical management benefit some patients, 20--40% of OCD patients---often those most severely affected---remain refractory to treatment (Skoog and Skoog, [@B146]). Lesion procedures such as anterior capsulotomy and dorsal cingulotomy have been available to patients with refractory OCD for over 40 years (Dougherty et al., [@B56]; Mian et al., [@B112]), however, these procedures have the disadvantage of being irreversible. In 1999, DBS was introduced as a neurosurgical treatment for OCD (Nuttin et al., [@B119]) with the advantage of being reversible and adjustable. In early clinical trials, two-thirds of OCD patients treated with DBS showed a statistically significant improvement in symptoms and global functioning (Greenberg et al., [@B68]).

Despite the clinical benefit of DBS, the mechanisms underlying its therapeutic success remain unclear. First hypothesized to mimic ablative procedures and produce the functional equivalent of a lesion (Nuttin et al., [@B119]), animal and human studies have indicated a more complex neurophysiological effect. OCD is thought to arise from abnormal neural activity in the CSTC circuit, a network involving ACC, OFC, dorsolateral prefrontal cortex (DLPFC), ventral striatum, MD thalamus, and amygdala (Rauch et al., [@B127]; Rotge et al., [@B130], [@B131]; Haber and Brucker, [@B73]; den Braber et al., [@B48]). Studies of DBS have elucidated local cellular mechanisms that influence the function of both the stimulated target area and distant regions, which may ultimately modulate pathological network activity in the CSTC circuit. In this article, we first review the pathophysiology of OCD before examining the basic mechanisms of action of DBS and applying what is known about these mechanisms to understand how DBS functions in OCD. We analyze the results of neuroimaging studies, intraoperative human recordings, and *in vivo* and *in vitro* animal studies of DBS in order to inform our knowledge of the mechanisms of DBS and how this increases our understanding of the pathophysiology of OCD.

Pathology of OCD
================

The CSTC-based theory of behavioral control serves as a useful model for the investigation of mental health disorders such as OCD (Figure [1](#F1){ref-type="fig"}). OFC is a critical cortical component of the CSTC implicated in OCD, and extensive evidence links OFC dysfunction to OCD. Positron emission tomography (PET) studies in patients with OCD have identified increased metabolism in OFC in the resting state (Baxter et al., [@B18], [@B20]) and increased activity with symptom provocation has also been observed with PET and functional magnetic resonance imaging (fMRI). (McGuire et al., [@B107]; Rauch et al., [@B128]; Adler et al., [@B2]). Additionally, OFC PET metabolism elevation is correlated with anxiety levels in OCD patients (Swedo et al., [@B150]). OFC activation with obsessions is not limited to the pathologic state; increased OFC activity is also seen with PET during stimulation of obsessive thoughts in healthy controls (Cottraux et al., [@B43]). A PET study showed that OFC metabolism decreases with pharmacologic treatment, and this decrease correlates with several measures of improvement in OCD symptoms (Swedo et al., [@B149]). The medial OFC (mOFC) and lateral OFC (lOFC) may be differentially involved in OCD. The mOFC is active in emotional regulation and positive valence processing while the lOFC processes negative reinforcers and fear response (Kringelbach and Rolls, [@B87]). In OCD, there may be increased lOFC and decreased mOFC activity (Milad and Rauch, [@B113]), although findings are somewhat inconsistent (Milad and Rauch, [@B114]). The OFC is also involved in behavioral planning and expected reward valuation. Dysfunctions of these processes are likely involved in the repetitive compulsions and driving obsessions of OCD, and may be represented by the altered OFC activity seen in this disease.

![**Cortico-striato-thalamocortical circuit.** Schematic diagram of the cortico-striato-thalamocortical (CSTC) circuit, which is implicated in the pathophysiology of OCD. In DBS for OCD, activity within this circuit is thought to be modulated by high frequency stimulation. DLPFC, dorsolateral prefrontal cortex; ACC, anterior cingulate cortex; OFC, orbitofrontal cortex; VMPFC, ventromedial prefrontal cortex. Arrowheads indicate direction of neural input. Black lines represent connections among the major structures implicated in DBS for OCD; gray lines indicate additional connections.](fnint-06-00029-g0001){#F1}

ACC plays a role in motivation and conflict monitoring, as well as determining discrepancies between desired and anticipated state (Graybiel and Rauch, [@B67]; Del Casale et al., [@B47]). These functions are important in OCD, in which obsessions and compulsions may be in part due to dysfunctional reward signaling and aberrant signaling of conflict between desired and current state. PET and single photon emission computed tomography (SPECT) studies have demonstrated increased ACC metabolism in OCD patients at rest (Swedo et al., [@B150]; Machlin et al., [@B97]; Perani et al., [@B123]) and PET and fMRI studies have also found increased ACC activity with symptom provocation (Rauch et al., [@B128]; Breiter et al., [@B32]; Adler et al., [@B2]) and error or high conflict trials on an interference processing task (Fitzgerald et al., [@B60]; Maltby et al., [@B102]; Schlosser et al., [@B137]). ACC metabolism measured with PET decreases following treatment with selective serotonin reuptake inhibitors (SSRIs), correlating with decreases in Yale Brown Obsessive Compulsive Scale (Y-BOCS) score (Perani et al., [@B123]), a commonly used metric of OCD severity. Interestingly, increased PET ACC metabolism prior to treatment is seen in clomipramine non-responders (Swedo et al., [@B150]), perhaps representing a degree of severity or a marker of different pathological underpinnings resistant to pharmacologic therapy. Lesion of the dorsal anterior cingulate (cingulotomy) can result in long-term improvement in OCD symptoms in patients refractory to pharmacologic and behavior therapy (Dougherty et al., [@B56]). The cingulate cortex has close connections to motor cortex and participates in action selection. Graybiel and Rauch suggest that OFC and ACC together have a strong influence on perceived value and corresponding action selection (Graybiel and Rauch, [@B67]). The altered activity of both of these structures seen in OCD may represent abnormal function and interaction of OFC and ACC in OCD contributing to dysfunctional valuation and repetitive actions characteristic of OCD.

The basal ganglia participate in multiple parallel cortico-basal ganglia circuits and are important in motor inhibition and release. It has been hypothesized that an analogous role exists in cognitive circuits in parallel with motor circuitry and may be involved in the pathophysiology of OCD (Saxena et al., [@B134]; Graybiel and Rauch, [@B67]). In particular, the caudate nucleus has been implicated in OCD. The caudate plays a role in procedural learning and may contribute to abnormal processing of behavioral sequences generated by frontal subcortical circuits that have been hypothesized to exist in OCD (Graybiel and Rauch, [@B67]; Saxena and Rauch, [@B135]). Structural studies have shown altered caudate volume in OCD (Luxenberg et al., [@B96]; Scarone et al., [@B136]; Robinson et al., [@B129]), with decreased N-acetyl-aspartate (NAA), thought to be a marker of neuronal density, in caudate and putamen (Ebert et al., [@B57]; Bartha et al., [@B16]). Functionally, caudate activity measured with PET is increased at rest (Baxter et al., [@B18], [@B20]) and increased activity during symptom provocation has been observed with PET and fMRI (Rauch et al., [@B128]; Breiter et al., [@B32]; Simon et al., [@B145]), correlating with symptom intensity (McGuire et al., [@B107]), with decreased activity measured with PET correlating with improvement in symptoms following pharmacologic (Benkelfat et al., [@B25]) or behavioral therapy (Baxter et al., [@B19]). OCD patients have decreased dopamine D2 receptor binding (Denys et al., [@B51]) and increased dopamine transporter density (van der Wee et al., [@B155]) in the caudate, suggesting dysfunction of this structure and perhaps altered dopaminergic tone in OCD.

As part of the involved CSTC circuit, the thalamus has also been studied in OCD, with some PET study evidence showing increased activity in the resting state (Swedo et al., [@B150]; Perani et al., [@B123]) and with increased blood flow measured with H~2~^15^O PET correlating with symptom intensity during symptom provocation (McGuire et al., [@B107]). Prior to treatment, OCD patients showed correlation of OFC activity measured with PET with ipsilateral caudate and thalamus activity, but this correlation disappeared after successful pharmacologic or behavioral therapy (Baxter et al., [@B19]; Schwartz et al., [@B138]), suggesting that abnormal signaling between these regions may be involved in OCD pathophysiology (Modell et al., [@B116]).

In the medial temporal cortex, the hippocampus and amygdala bear connections to each other and the prefrontal cortex (PFC), and these regions may play a role in the pathophysiology of OCD. The amygdala is critically involved in the association of external stimuli with emotional value and the acquisition of conditioned fear responses (Aggleton, [@B3]; Cahill and McGaugh, [@B37]). The hippocampus integrates spatial and affective information (Sesack and Grace, [@B140]) and is necessary for context-dependent fear conditioning (Fanselow, [@B58]; Maren and Quirk, [@B103]) and the behavioral response to stress (Bouton and Bolles, [@B30]; Bouton and King, [@B31]), among other functions. Thus, abnormal activity in these structures may underlie the anxiety triggered by provocative simuli which often accompanies a patient\'s urge to perform compulsions.

Multiple imaging studies have highlighted functional and structural abnormalities in these regions among patients with OCD as compared to healthy controls. A positive correlation between symptom intensity and blood flow in the left hippocampus has been demonstrated using PET (McGuire et al., [@B107]). fMRI has also revealed increased activation of the medial temporal cortex when unmedicated patients are exposed to provocative stimuli that triggers OCD symptoms (Adler et al., [@B2]). In structural MRI studies, the mean volume of the hippocampus and amygdala is decreased among OCD patients (Kwon et al., [@B89]), and OCD severity appears to be correlated with left hippocampal volume (Atmaca et al., [@B12]; Atmaca, [@B10]). MRI has also shown bilateral hippocampal shape deformity, which may reflect altered neural connections (Hong et al., [@B78]). Researchers employing proton magnetic resonance spectroscopy found decreased NAA/CR (N-acetyl-aspartate/creatine) and NAA/CHO (N-acetyl-aspartate/choline) ratios (Atmaca et al., [@B11]). Reductions in NAA, a primarily intracellular metabolite, are thought to indicate a loss of neurons. Increases in creatine, an energetic marker, and CHO, a component of some phospholipids, are thought to reflect membrane breakdown. Thus, these ratios suggest hippocampal degeneration.

Despite these results, not all imaging studies have identified a significant effect in the amygdala and/or hippocampus (Busatto et al., [@B36]; Saxena et al., [@B133]). These discrepancies may arise from variations in the pathophysiology of OCD depending on severity or subtype of obsessions. In a study using proton magnetic resonance spectroscopy, patients with autogenous obsessions, which do not emerge in response to identifiable external stimuli, had elevated NAA/CR ratios in the amygdala and hippocampus. This increase was not observed in the same brain regions of healthy controls or patients with reactive obsessions, a subtype of OCD in which obsessions are evoked by specific external stimuli (Besiroglu et al., [@B26]). In contrast, altered energy metabolism was found in the ACC, a commonly implicated brain region in the pathology of OCD, in patients with either subtype of OCD. These results suggest that patient categorization within OCD may reveal effects masked when OCD is studied as a homogenous disorder. Such consideration of heterogeneity may be most important when investigating regions that have only been weakly implicated in OCD, but may nonetheless significantly affect pathology and, in turn, treatment, in certain forms of OCD. Although the hippocampus and amygdala have received less attention in the literature than ACC or OFC, these regions may garner greater focus in the future, given recent evidence that the ameliorating effect of OCD treatments may arise, in part, from hippocampal neurogenesis (Derrick et al., [@B52]; Bruel-Jungerman et al., [@B33]; Chun et al., [@B42]; Kitamura et al., [@B85]; Stone et al., [@B147]).

Mechanisms of action of DBS
===========================

The longest established application of DBS is for the treatment of Parkinson\'s disease (PD). Accordingly, the majority of studies of the local and cellular effects of high frequency stimulation (HFS) pertain to stimulation of STN or globus pallidus internus (GPi), the two structures targeted for treatment of this disease. Nonetheless, some mechanisms may be generalizable to DBS for OCD, thus warranting their review (Table [1](#T1){ref-type="table"}).

###### 

**Mechanisms of action of DBS**.

  **Mechanisms of action of DBS**
  ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Local inhibition --Conduction block --Buildup of K+ in submyelin space--Inactivation of Na+ channels--Depletion of neurotransmitter (glutamate)--Release of inhibitory neurotransmitters --Adenosine--GABA--Hyperpolarization of somaLocal excitation --Axonal activation --antidromic--orthodromic--Glutamate release from astrocytesModulation of temporal firing pattern --Desynchronization of neural firing--Suppression of information transmission through regionNeurogenesis --Generation of DGCs--Integration of DGCs into hippocampal circuits

DGCs: dentate gyrus cells.

DBS as functional lesion-mechanisms of local inhibition
=======================================================

The clinical outcomes of ablative neurosurgical techniques, such as anterior capsulotomy and cingulotomy, resemble those of DBS, which has prompted comparisons of DBS to a lesion (Nuttin et al., [@B119]). Inactivation of the STN via injections of lidocaine or the gamma-aminobutyric acid (GABA) agonist muscimol alleviates parkinsonian motor symptoms in 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treated primates (Wichmann et al., [@B161]) and humans with PD (Levy et al., [@B92]). Muscimol injection into the ventralis intermedius thalamus of humans has also been shown to alleviate tremor (Pahapill et al., [@B122]), suggesting that DBS might achieve its similar therapeutic effect through local inhibition (Table [1](#T1){ref-type="table"}). Single unit extracellular recordings in animal studies of HFS, the experimental equivalent of DBS, of the STN, GPi, and thalamus have shown suppression of neuronal activity in the targeted region (Benazzouz et al., [@B24]; Boraud et al., [@B29]; Benazzouz and Hallett, [@B23]; Tai et al., [@B151]; Meissner et al., [@B111]). Human studies of DBS of the STN (Filali et al., [@B59]; Welter et al., [@B160]) and GPi (Dostrovsky et al., [@B55a]) using single unit recordings have also shown local inhibition. However, not all studies have corroborated these results; single unit recordings conducted during DBS of STN in humans did not show suppression of the stimulated region (Carlson et al., [@B39]). Such discrepancies are quintessential of the study of DBS thus far, which indicates that DBS may evoke multiple effects, with the weight of any given mechanism varying.

Evidence for different mechanisms of local inhibition has emerged, including conduction block, depletion of neurotransmitter, and activation of inhibitory inputs. HFS may cause a conduction block via a buildup of K+ in the submyelin space (Bikson et al., [@B28]; Lian et al., [@B94]; Bellinger et al., [@B22]) and axonal depolarization that inactivates Na+ channels (Beurrier et al., [@B27]; Kiss et al., [@B84]). Depolarization may also result in glutamatergic release and subsequent depression due to depletion of the neurotransmitter pool, as has been shown in *in vitro* studies of HFS of the thalamus in rodent brain slices (Urbano et al., [@B154]; Anderson et al., [@B7]; Iremonger et al., [@B80]).

Release of inhibitory neurotransmitters may also suppress neuronal activity. HFS has been shown to evoke release of adenosine triphosphate (ATP) in the *in vitro* rodent slice, resulting in increased extracellular adenosine levels and suppression of thalamic activity via activation of the adenosine A1 receptor (Bekar et al., [@B21]). GABAergic afferent inputs may also play a signficant role in stimulation induced inhibition, especially considering that stimulation more readily activates axon terminals than local cells near an electrode (Baldissera et al., [@B14]; Jankowska et al., [@B81]; Gustafsson and Jankowska, [@B72]). Lee and colleagues ([@B91]) found that STN stimulation *in vitro* causes local GABA mediated postsynaptic potentials. Microstimulation of the GPi appears to cause preferential activation of GABAergic axons (Dostrovsky et al., [@B55a]), possibly due to the predominance of GABAergic over glutamatergic terminals in the GPi (Shink and Smith, [@B144]) indeed, while stimulating in a region with greater glutamatergic inputs, the thalamus, Dostrovsky and colleagues ([@B55]) observed postsynaptically mediated excitation. Results such as these---excitation in one brain region, inhibition in another---exemplify the diversity of findings regarding the mechanisms of DBS, indicating that the neurophysiological effects of DBS are more nuanced than those of a lesion. The overall effect may depend in part on characteristics of the region being stimulated and the convergence of opposing mechanisms.

Neurophysiological response of a neuron to HFS
==============================================

Computational models suggest that DBS has a decoupling effect within the individual neuron, causing inhibition of the soma and excitation of the axon (McIntyre et al., [@B109]; Miocinovic et al., [@B115]). The influence of an electric field on a cell is related to the second derivative of the extracellular potential distribution along each process of a neuron (McNeal, [@B110]; Rattay, [@B125]). As a result, stimulation both hyperpolarizes and depolarizes a neuron, depending on the geometric relationship of the electrode to the cell (McIntyre and Grill, [@B108]; Rattay, [@B126]). With the complex three-dimensional branching of the dendritic arbor, neurons experience hyperpolarization and depolarization, with the soma tending to hyperpolarize and the axon hillock depolarizing, potentially triggering an action potential. The concentration of inhibitory inputs on the proximal dendrites and soma may also enhance this hyperpolarization of the soma, particularly since axon terminals, including GABAergic inputs, are readily activated by HFS (McIntyre et al., [@B109]). Models have also demonstrated that HFS can cause antidromic activation and "re-orthodromic" activation, in which the action potential propagates into the terminal. Antidromic activation only occurs when the diameters of each axonal process fall under a threshold, and propagation significantly depends on the geometry of the node of Ranvier at the axonal bifurcation (Grill et al., [@B71]).

Experimental results in the rodent and human accord with these models; electrical stimulation in gray matter activates axons but not cell bodies (Nowak and Bullier, [@B118]). With HFS of the STN, some STN neurons exhibit an increased discharge rate (Tai et al., [@B151]), which is hypothesized to arise from activation of glutamatergic afferents. Electrophysiological recordings during HFS of the STN have also shown increased output to recipient nuclei from the targeted region, through either orthodromic or antidromic activation (Windels et al., [@B162]; Hashimoto et al., [@B77]; Maurice et al., [@B104]). Li and colleagues ([@B93]) reported antidromic activation of deep layer cortical neurons during HFS of the STN. With simultaneous multisite LFP recordings during HFS of the NAc, researchers observed inhibition of the OFC, which they linked to antidromic activation of corticostriatal projections to cortical inhibitory interneurons (McCracken and Grace, [@B105]). Inhibition of the output structures of the basal ganglia, including the substantia nigra pars reticulara (SNr) and GPi, has also been demonstrated in rodents and may arise through a similar mechanism (Burbaud et al., [@B35]; Benazzouz et al., [@B24]; Benazzouz and Hallett, [@B23]; Anderson et al., [@B6]). Thus, activation of axons may have distal effects, inducing overall excitation or inhibition through stimulation of inhibitory interneurons.

Modulation of temporal firing pattern
=====================================

Rather than inducing complete local inhibition, DBS may partially dampen neural activity and reshape firing patterns. In the diseased state, target regions often display abnormal firing patterns. In rats with substantia nigra pars compacta (SNC) lesion induced parkinsonian behaviors, STN neurons exhibit an irregular bursting pattern as compared to normal rats, despite equivalent mean firing rates (Tai et al., [@B151]). Moreover, HFS of the rodent STN has been shown to alter the bursting pattern of STN neurons, with no inhibition of the region\'s intrinsic activity (Zheng et al., [@B165]). This modification of the temporal firing pattern can result in desynchronization of the firing of STN neurons (Degos et al., [@B46]). Similar modulation has been demonstrated in the globus pallidus (GP); during HFS of the GP in MPTP-treated primates the majority of neurons in the GP exhibited complex locking to the stimuli, with a stereotypic temporal structure (Bar-Gad et al., [@B15]). The temporal firing pattern of the GP is also modulated by HFS of the STN (Hashimoto et al., [@B77]). This reshaping of temporal dynamics may affect information transmission. Degos et al. ([@B46]) and Zheng et al. ([@B165]) found that HFS of the STN decreased, but did not completely interrupt, transmission of information through the STN and regions of the basal ganglia. Thus, HFS may partially uncouple the targeted site from upstream and downstream regions while not significantly altering the intrinsic activity of the site. Debate remains concerning the primary mechanism of this uncoupling; some researchers have implicated synaptic inhibition (Deniau et al., [@B49]), while others have postulated axonal failure (Zheng et al., [@B165]).

Neurogenesis and plasticity
===========================

In contrast to DBS for PD, the therapeutic effect of DBS for OCD takes weeks to months to manifest, which raises the possibility of additional mechanisms beyond acute alteration firing rates and patterns. Similar to recent findings with the use of SSRI (Malberg et al., [@B98]; Santarelli et al., [@B132]), a common treatment for OCD, DBS may induce hippocampal neurogenesis. Multiple studies have demonstrated proliferation and/or survival of dentate gyrus cells (DGCs) *in vivo* following tetanic stimulation of mossy fibers, the entorhinal cortex, or perforant path in rodents (Derrick et al., [@B52]; Bruel-Jungerman et al., [@B33]; Chun et al., [@B42]; Kitamura et al., [@B85]; Stone et al., [@B147]). Behavioral correlates, involving enhancement of memory and learning, have also been demonstrated following stimulation, depending on the time lapse between stimulation and testing. Hamani and colleagues administered HFS to the anterior thalamic nucleus (ATN) of corticosterone treated rats, which is known to reduce neurogenesis and diminish learning and memory performance (Hamani et al., [@B75]). Thirty-three days later, the stimulated rodents performed significantly better on a common memory test, a delayed non-matching to sample task, as compared to their unstimulated, corticosterone treated counterparts. This behavioral enhancement was not evident prior to 33 days, suggestive of long-term plastic changes. Time may also explain a discrepancy in the literature, in which ATN HFS was shown to impair rodents\' contextual fear conditioning (Hamani et al., [@B74]); the researchers did not wait as long to test the rodents as in their subsequent study (Hamani et al., [@B75]). Stone and colleagues ([@B147]) also reported enhancement of mouse spatial memory at 6 weeks, but not 1 week, following bilateral entorhinal cortex stimulation. Corresponding to these time points, integration of DGCs into dentate circuits was observed at 6 weeks but not 1 week following stimulation. When the DNA alkylating agent temozolomide (TMZ) was used to obstruct adult neurogenesis, the previous improvements in spatial memory were not apparent, further substantiating a role of HFS in adult neurogenesis with behavioral effect. Given the abnormalities observed in the hippocampus in imaging studies, hippocampal neurogenesis, and in turn, HFS, may have an ameliorating effect among such patients.

Variability of the local effect of HFS
======================================

As shown by the studies described above, a variety of findings have emerged in the study of mechanisms of DBS. While several studies have demonstrated partial failure of axonal conduction with low fidelity to the frequency of stimulation (Urbano et al., [@B154]; Zheng et al., [@B165]), others have reported driving of neurons at the same frequency as stimulation (Garcia et al., [@B65]; Hashimoto et al., [@B77]; Li et al., [@B93]). Differences between *in vivo* and *in vitro* preparations, brain regions, species, and normal and diseased tissue may affect the proportion of blocked to transmitted action potentials and contribute to this discrepancy (Zheng et al., [@B165]). Variations between regions in neural and glial cell types as well as the proportion of local cells versus fibers of passage and afferent inputs may also alter the response of the region to stimulation. For example, some neurons of the STN display a resurgent Na+ current which is modified by HFS (Do and Bean, [@B54]). In contrast, a similar current has never been demonstrated in the thalamus, which may explain contrasting results from studies of HFS of this region (Anderson et al., [@B7]). Glia, which vary among regions, may also have a pronounced influence on the effect of HFS: Tawfik and colleagues ([@B151a]) demonstrated that HFS of the thalamus causes release of glutamate from astrocytes, concurrent with an abolition of spindle activity in the thalamocortical network. Even within a given region, multiple neural response types are often identified (Maurice et al., [@B104]; Tai et al., [@B151]; Deniau et al., [@B49]; Zheng et al., [@B165]); such variability may render the results of HFS of one region less comparable to another.

Although the mechanisms of DBS still remain unclear, this diversity of findings may indicate that many of these mechanisms occur, with the predominance of their respective effect dependent on disease state and regional factors. Despite the possible specificity of findings to target regions, a general hypothesis may emerge from the debate---DBS suppresses pathological network activity, while allowing normal information transmission to occur.

Effect of DBS on OCD circuitry
==============================

While DBS for OCD is a relatively new treatment, several functional imaging and animal studies exist investigating the functional changes underlying the therapeutic effects of DBS. We examine these in the context of the mechanisms of action of DBS in order to better understand how DBS effects therapeutic benefit in OCD.

STN stimulation
===============

STN DBS was initially investigated for OCD because of effects on similar symptoms noted in PD patients. PD patients treated with STN DBS have decreased obsessive compulsive traits (Alegret et al., [@B4]). Case reports of 3 PD patients treated with STN DBS who incidentally had comorbid OCD reported substantial improvement of OCD symptoms with STN stimulation (Mallet et al., [@B99]; Fontaine et al., [@B61]). In all three patients the electrode location was more medial than the standard PD target, likely contributing to this effect. Subsequently a clinical trial with patients randomized to actual or sham stimulation in a crossover design showed that OCD patients with STN DBS targeted to the border of the associative and limbic territories of the STN, anteromedial to the standard PD target, showed significant improvement in Y-BOCS scores with stimulation (Mallet et al., [@B100]). Stimulation related side effects of STN DBS in OCD patients include transient dyskinesia, peripheral vertigo, hypomania, mania, depression, and anxiety (Mallet et al., [@B100]).

Similar to STN DBS in humans, STN HFS decreases OCD like behavior in animal models, and this modification may occur due to the inhibitory and excitatory mechanisms discussed previously. STN HFS and pharmacologic inactivation in a rat model both decrease OCD like behavior (Winter et al., [@B164]; Klavir et al., [@B86]), suggesting that HFS and lesion act similarly in this paradigm. Anterior STN HFS decreases stereotypic behaviors in primates with stereotypies induced by injection of the GABA antagonist bicuculline into the limbic globus pallidus externus (GPe) (Baup et al., [@B17]). STN stimulation decreases firing of SNr and entopeduncular nucleus (EP, a GPi homolog) neurons while increasing activity of GPe neurons (Benazzouz et al., [@B24]). STN receives efferent connections from GPe and projects to GPi and SNr. GPe projections terminate near STN cells originating connections to GPi and SNr (Joel and Weiner, [@B82]) thus stimulation may inhibit STN neural firing and output to SNr and GPi while being in a position to retrogradely activate GPe axons. In this way STN stimulation may disrupt the abnormal GPe activity induced by bicuculline injection in the primate model. Anatomic studies of this model have shown that the GPe region that induces stereotypic behaviors when injected with bicuculline receives projections from dorsal NAc/ventral head of the caudate nucleus and projects mostly to SNr with some projections to GPi (Francois et al., [@B62]). Thus, it is connected to structures known to be involved in OCD and may modulate activity of circuits involved in OCD or dopaminergic tone, which may be altered in this condition. The predictions of this model may have implications for human pathology and STN DBS for OCD. Modulation of GPi and GPe activity may alter signaling in cortico-basal ganglia circuits involved in OCD. Overall, these findings provide support to the theory that DBS, at least in the STN, inhibits local neurons and their output but causes antidromic activation of efferent projections and via these mechanisms modulates activity of regions of pathologic brain activity in OCD.

Research in rats has shown altered neurotransmitter concentrations in a number of structures with STN stimulation. Striatal dopamine increases with STN stimulation in rats (Bruet et al., [@B34]; Lee et al., [@B89a]). STN stimulation caused a nonsignificant trend toward increased dopamine in the NAc core and a significant increase of dopamine in the NAc shell as well as decreased GABA in the ventral tegmental area (VTA) (Winter et al., [@B163]). In this study VTA lesions prevented STN stimulation induced modulation of NAc dopamine levels suggesting that STN stimulation acts via activation of VTA dopaminergic neurons to increase dopamine in the NAc. Dopaminergic signaling in the NAc is involved in motivation and reward; STN DBS induced alteration of NAc dopamine levels may combat abnormal reward processing in OCD.

Several functional imaging studies provide insight into altered metabolism induced by STN DBS (Table [2](#T2){ref-type="table"}). In two PD patients, stimulation of electrode contacts near the border of the associative and limbic regions of the STN, a location similar to that used in OCD, induced a hypomanic state; stimulation of these contacts decreased medial prefrontal cortex (mPFC)/anterior cingulate gyrus and increased left thalamus activation imaged with PET (Mallet et al., [@B101]). OCD patients treated with STN DBS had decreased metabolism in the anterior cingulate gyrus and medial gyrus of the left frontal lobe during PET imaging, with decrease in Y-BOCS scores correlating with decreases in OFC and mPFC metabolism (Le Jeune et al., [@B90]). STN DBS may modulate reciprocal direct connections that exist between the STN and PFC (Degos et al., [@B45]), thereby causing the observed alterations in prefrontal activity (Le Jeune et al., [@B90]). An alternative explanation is that STN stimulation alters activity of subcortical components of the CSTC circuit, perhaps by altering activity of the GP, one of the primary basal ganglia output structures, as discussed above. Ultimately it appears that STN stimulation decreases ACC activity and that therapeutic effects are additionally related to decreased OFC metabolism. Interestingly, PET studies have shown decreased metabolism in these two areas with pharmacologic therapy (Swedo et al., [@B149]; Perani et al., [@B123]) and cingulotomy can be an effective treatment for patients refractory to pharmacologic and behavioral therapy. These findings suggest that altered activity of OFC and ACC is a key part of the dysfunctional circuitry of OCD and that modulation of this abnormal activity is common to the mechanism of action of behavioral, pharmacologic, and surgical therapy.

###### 

**Findings of functional imaging studies during stimulation of DBS targets used for OCD**.

                                          **STN DBS**                                                                                              **ALIC DBS**                                                                                                                                                                                                                                                                                                                                                       **VC/VS DBS**
  --------------------------------------- -------------------------------------------------------------------------------------------------------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ -----------------------------------------------
  Medial PFC                              ↓ Mallet et al., [@B101]                                                                                 ---                                                                                                                                                                                                                                                                                                                                                                ---
  DLPFC                                   ---                                                                                                      ↑↓ Baker et al., [@B13]; Van Laere et al., [@B159]                                                                                                                                                                                                                                                                                                                 ---
  ACC                                     ↓ Mallet et al., [@B101]; Le Jeune et al., [@B90]                                                        ↑↓ Baker et al., [@B13]; Van Laere et al., [@B159]                                                                                                                                                                                                                                                                                                                 ↑ Baker et al., [@B13]
  Posterior cingulate                     ---                                                                                                      ↑ Baker et al., [@B13]                                                                                                                                                                                                                                                                                                                                             ↑ Baker et al., [@B13]
  OFC                                     ---                                                                                                      ↓ Abelson et al., [@B1]                                                                                                                                                                                                                                                                                                                                            ↑ Rauch et al., [@B127]
  Medial frontal gyrus                    ↓ Le Jeune et al., [@B90]                                                                                ---                                                                                                                                                                                                                                                                                                                                                                ---
  Superior frontal gyrus                  ---                                                                                                      ---                                                                                                                                                                                                                                                                                                                                                                ↑ Baker et al., [@B13]
  Middle frontal gyrus                    ↑ Baker et al., [@B13]                                                                                   ---                                                                                                                                                                                                                                                                                                                                                                ↑ Baker et al., [@B13]
  Inferior frontal gyrus                  ↑ Mallet et al., [@B101]                                                                                 ---                                                                                                                                                                                                                                                                                                                                                                ↑ Baker et al., [@B13]
  Frontal cortex                          ---                                                                                                      ↑↓ Nuttin et al., [@B120]                                                                                                                                                                                                                                                                                                                                          ---
  Insula                                  ---                                                                                                      ↓ Van Laere et al., [@B159]                                                                                                                                                                                                                                                                                                                                        ---
  Inferior parietal gyrus                 ↑ Mallet et al., [@B101]                                                                                 ---                                                                                                                                                                                                                                                                                                                                                                ---
  Superior temporal gyrus                 ---                                                                                                      ↑ Nuttin et al., [@B120]                                                                                                                                                                                                                                                                                                                                           ---
  Middle temporal gyrus                   ↑↓ Mallet et al., [@B101]                                                                                ↑ Nuttin et al., [@B120]                                                                                                                                                                                                                                                                                                                                           ---
  Inferior temporal gyrus                 ↑ Mallet et al., [@B101]                                                                                 ---                                                                                                                                                                                                                                                                                                                                                                ---
  Middle occipital gyrus                  ↓ Mallet et al., [@B101]                                                                                 ---                                                                                                                                                                                                                                                                                                                                                                ---
  Lateral occipital cortex                ---                                                                                                      ↑ Nuttin et al., [@B120]                                                                                                                                                                                                                                                                                                                                           ---
  Bilateral cuneus                        ↓ Mallet et al., [@B101]                                                                                 ---                                                                                                                                                                                                                                                                                                                                                                ---
  Striatum                                ---                                                                                                      ↑↓ Nuttin et al., [@B120]; Van Laere et al., [@B159]                                                                                                                                                                                                                                                                                                               ---
  Caudate                                 ---                                                                                                      ↑ Baker et al., [@B13]                                                                                                                                                                                                                                                                                                                                             ↑ Baker et al., [@B13]
  Globus pallidus                         ---                                                                                                      ↑ Baker et al., [@B13]                                                                                                                                                                                                                                                                                                                                             ↑ Rauch et al., [@B127]
  Putamen                                 ---                                                                                                      ↑ Baker et al., [@B13]                                                                                                                                                                                                                                                                                                                                             ↑ Baker et al., [@B13]; Rauch et al., [@B127]
  Amygdala                                ---                                                                                                      ↓ Van Laere et al., [@B159]                                                                                                                                                                                                                                                                                                                                        ---
  Thalamus                                ↑ Mallet et al., [@B101]                                                                                 ↑↓ Baker et al., [@B13]; Van Laere et al., [@B159]                                                                                                                                                                                                                                                                                                                 ↑ Baker et al., [@B13]; Rauch et al., [@B127]
  Pons                                    ---                                                                                                      ↑ Nuttin et al., [@B120]                                                                                                                                                                                                                                                                                                                                           ---
  Correlation with clinical improvement   Decrease in OFC/ventral medial PFC correlated with decrease in Y-BOCS scores (Le Jeune et al., [@B90])   Decrease in OFC metabolism seen in patients with clinical improvement (Abelson et al., [@B1]); negative correlation of decreased left hippocampus and left posterior cingulate metabolism with Y-BOCS scores, positive correlation of reduced left amygdala and left head of the caudate neucleus metabolism with decrease in Y-BOCS (Van Laere et al., [@B159])   ---

Arrows indicate direction of change in activity with stimulation of the indicated target.

Anterior limb of the internal capsule and ventral striatum stimulation
======================================================================

A number of case reports have documented benefit of stimulation of ALIC or a more ventral target in the ventral ALIC and ventral striatum which includes the NAc and is termed ventral capsule/ventral striatum (VC/VS) (Anderson and Ahmed, [@B5]; Gabriels et al., [@B64]; Franzini et al., [@B63]). This benefit seems to persist even with blinding to stimulation state (Nuttin et al., [@B119]). Larger trials using randomized, blinded assignment to stimulation versus sham stimulation have strengthened evidence of benefit of DBS in these regions (Nuttin et al., [@B120]; Abelson et al., [@B1]; Denys et al., [@B50]; Goodman et al., [@B66]), with a study of VC/VS stimulation showing significant sustained improvement in Y-BOCS scores at three years following surgery (Greenberg et al., [@B70]). Unilateral ALIC/NAc DBS has also been studied and shown to have some effect (Sturm et al., [@B148]; Huff et al., [@B79]). Finally, case reports of stimulation of the ventral caudate in addition to the NAc have shown significant decrease in Y-BOCS scores (Aouizerate et al., [@B9], [@B8]). Several side effects have been reported with ALIC and VC/VS stimulation. Several reports have described unilateral cheek muscle contraction with acute ALIC stimulation, corresponding with increased mood (Baker et al., [@B13]). Paresthesias and nausea have been associated with higher voltage stimulation, perhaps especially with stimulation of ventral contacts 0 and 1 (Abelson et al., [@B1]; Baker et al., [@B13]). Fatigue lasting for several months and weight changes, both loss and gain, have been noted (Nuttin et al., [@B120]). Elevated mood, hyperactivity, dysinhibition, increased talkativeness, irritability, and decreased need for sleep, sometimes reaching the level of mania or hypomania may occur with ALIC stimulation, especially at higher stimulation voltages and with stimulation of ventral contacts (Gabriels et al., [@B64]; Nuttin et al., [@B120]; Abelson et al., [@B1]; Chang et al., [@B40], [@B41]). VC/VS stimulation may also induce impulsive behavior, hypomania or mania (Denys et al., [@B50]; Goodman et al., [@B66]; Greenberg et al., [@B68]; Haq et al., [@B76]; Tsai et al., [@B153]; Luigjes et al., [@B95]). Similarly to ALIC stimulation, unilateral smile is common with VC/VS acute stimulation (Greenberg et al., [@B70], [@B68]; Goodman et al., [@B66]). Some patients experience transient stomachaches or nausea with VC/VS stimulation (Okun et al., [@B121]; Denys et al., [@B50]). Other reported side effects include headaches, cold shivers, difficulty falling asleep, and paresthesias (Okun et al., [@B121]; Denys et al., [@B50]; Greenberg et al., [@B68]; Huff et al., [@B79]). Some patients report cognitive effects such as forgetfulness, word finding difficulties, verbal perseveration, cognitive clouding, or decreased concentration (Okun et al., [@B121]; Denys et al., [@B50]; Greenberg et al., [@B68]; Huff et al., [@B79]). VC/VS stimulation can cause acute emotional changes such as euphoria, sadness, or anxiety occasionally reaching the level of panic attack (Greenberg et al., [@B70], [@B68]; Goodman et al., [@B66]; Huff et al., [@B79]). Panic and anxiety may be associated with autonomic changes and occur more frequently with stimulation of ventral contacts (Shapira et al., [@B143]; Okun et al., [@B121]; Goodman et al., [@B66]). Changes in taste, either decreased taste sensation or transient olfactory and gustatory sensations may occur with VC/VS stimulation, especially with ventral contact stimulation (Greenberg et al., [@B70], [@B68]; Okun et al., [@B121]; Denys et al., [@B50]; Goodman et al., [@B66]). Overall, stimulation induced adverse events are more likely to occur with stimulation of ventral contacts (Greenberg et al., [@B70]). Transient hypomania is the most common side effect experienced immediately after stimulation is begun and is more common with VC/VS than STN stimulation (de Koning et al., [@B44]). In general, stimulation induced adverse effects are almost always transient and remit with alteration of stimulation settings.

Stimulation of the NAc core and shell may have different effects. Studies in rats have demonstrated decreased impulsivity and perseverative behavior with NAc core stimulation but increased impulsivity and decreased perseverative behavior with NAc shell stimulation (Sesia et al., [@B142], [@B141]). In contrast, NAc core lesions increase impulsivity while shell lesions do not (Pothuizen et al., [@B124]). NAc lesions have been reported to destroy the ability to hold reward value over time in a delayed reward task, resulting in impulsive behavior (Cardinal et al., [@B38]). This suggests that the effect of NAc stimulation is more complex than inhibition. The increase in impulsivity with NAc shell stimulation may be related to changes in local neurotransmitter concentrations: NAc shell HFS also increased concentrations of NAc dopamine and serotonin (Sesia et al., [@B141]), while NAc core stimulation does not in result in any local change in dopamine, serotonin, or noradrenaline concentrations (van Dijk et al., [@B156]). In human subjects NAc stimulation occasionally results in disinhibition, impulsiveness, or mania with increasing stimulation voltage (Haq et al., [@B76]; Luigjes et al., [@B95]) similarly to NAc lesion these effects may result from local inhibition and dysfunctional reward processing leading to impulsivity. Given the work by Sesia and colleagues it is possible that impulsivity is related to the effect of DBS on the NAc shell; alternatively stimulation could be causing an inhibitory effect analogous to a core lesion. The NAc core and shell have different inputs and projections, likely contributing to the observed differences between core and shell stimulation. The shell has reciprocal projections with VTA that may contribute to changes in dopamine concentrations with stimulation. STN stimulation also results in increased NAc dopamine concentrations, suggesting that NAc dopamine may be important for the observed therapeutic effects of DBS in OCD. However, increased NAc dopamine may also contribute to dysfunctional reward signaling and increased impulsivity which can be seen as a side effect of both STN and NAc stimulation.

HFS and low frequency stimulation (LFS) of the NAc have different effects on neural firing rates and patterns. NAc core HFS but not LFS increases slow local field potential (LFP) oscillations in OFC and decreases firing of OFC neurons, likely via antidromic activation of corticostriatal projections, activating inhibitory interneurons (McCracken and Grace, [@B105]). Low frequency NAc stimulation resulted in increased theta activity in MD thalamus and NAc, while HFS increased beta power in OFC and MD thalamus and gamma power in OFC, mPFC, and MD thalamus. HFS additionally increased beta coherence between MD thalamus and OFC, mPFC, and NAC and gamma coherence between OFC-PFC and OFC-MD thalamus while LFS decreased OFC-PFC and OFC-MD thalamus gamma coherence (McCracken and Grace, [@B106]). Because fast oscillations are generated by synchronization in inhibitory interneuron networks (Traub et al., [@B152]), the authors postulate that NAc HFS may generate therapeutic effects via synchronization of inhibition in dysfunctional OCD circuits. As discussed above, in untreated OCD patients correlation between OFC and ipsilateral thalamus and caudate activity measured with PET has been reported with disappearance of this correlation following treatment (Baxter et al., [@B19]; Schwartz et al., [@B138]); perhaps NAc DBS synchronizes inhibition of these pathologically hyperactive circuits. Interestingly, OCD patients have increased EEG theta power especially in frontal temporal and frontal occipital regions (Desarkar et al., [@B53]) and decreased beta power (Kuskowski et al., [@B88]), which one study reported localized to frontal regions (Serra et al., [@B139]). Thus, the therapeutic effects of NAc DBS may be related to the reversal of these abnormal oscillations.

Behavioral studies also support the different effects of NAc HFS and LFS. Stimulation of the NAc core or shell decreases compulsive behavior in rats (Mundt et al., [@B117]), however this effect is seen only with HFS and not with LFS (van Kuyck et al., [@B157]). In fact, increased compulsive behavior was observed in a rat repetitive and compulsive behavior model with NAc LFS or lesion (van Kuyck et al., [@B158]). The opposite effects of HFS and LFS on synchronization may be related to the increased compulsive behavior with LFS seen in this study. The similar behavioral effects of LFS and lesion in this study suggest that LFS of the NAc may have some inhibitory characteristics. The lesion like effects of both HFS and LFS in different behavioral experiments despite clear behavioral and neurophysiological effects of HFS and LFS when studied together demonstrate that the mechanism of DBS is more complicated than simple inhibition. Frequency modulation of antidromic and orthodromic axonal conduction and different effects on cell bodies and axons likely contribute to these complexities.

DBS in the region of the ALIC and the ventral striatum in OCD patients alters activity in structures known to be involved in OCD, particularly OFC and ACC (Table [2](#T2){ref-type="table"}). In one PET study ALIC DBS decreased OFC metabolism in two patients who benefited from stimulation but did not alter OFC metabolism in a third patient who experienced no benefit from DBS (Abelson et al., [@B1]), suggesting that modulation of OFC activity is important to the therapeutic effect of ALIC DBS. Frontal metabolism was decreased and striatal activity increased with ALIC DBS in two patients who underwent PET in one study (Nuttin et al., [@B120]). While studies of OCD patients generally indicate increased activity in areas such as OFC, caudate and ACC with decreased activity following successful treatment, discrepancies in findings suggest that OCD pathophysiology and therapeutic mechanisms are likely more complicated than simple increases and decreases in activity. Contrary to the findings of Nuttin and colleagues, Van Laere et al. used PET to find preoperative decreased metabolism in ventral PFC and dorsal anterior cingulate and increased metabolism in ventral striatum in a group of six OCD patients (Van Laere et al., [@B159]). Following several months of ALIC stimulation these patients demonstrated decreased metabolism in subgenual ACC and right DLPFC, with normalization of ventral striatum metabolism. Additionally, decrease in ventral striatum metabolism correlated with decrease in Y-BOCS scores while increased preoperative subgenual ACC activity was predictive of positive response to stimulation. Thus, ALIC DBS likely acts by modulating abnormal activity in circuits involving OFC, ACC, and striatum.

ALIC and VC/VS stimulation induce changes in activity in similar brain regions. In a case report of one patient with a VC/VS electrode studied with fMRI, stimulation of a contact located in the ALIC resulted in activation in the middle frontal gyrus, MD thalamus, ACC, head of the caudate nucleus, and GP. Stimulation of the ventral most contact in the same patient, located in the ventral striatum, also resulted in activation of MD thalamus and head of the caudate nucleus as well as posterior cingulate cortex and superior, middle, and inferior frontal gyrus (Baker et al., [@B13]). In a group of six patients with therapeutic benefit from VC/VS stimulation PET showed increased blood flow in mOFC, subgenual ACC, putamen, GP, and thalamus with stimulation (Rauch et al., [@B127]), although this study took place soon after electrode implantation and before subjects had been exposed to chronic stimulation which may alter the findings, especially considering the often delayed therapeutic effects of DBS for OCD. Overall, both VC/VS and ALIC stimulation seem to cause changes in activity in regions involved in OCD, including OFC, ACC, striatum, and thalamus. While the direction of change is not always consistent, this may reflect a modulation rather than inhibition of abnormal activity in these areas. One possible mechanism for changes observed with VC/VS stimulation is antidromic activation of corticostriatal fibers modulating CSTC circuits. OFC and ACC have bidirectional connections with thalamus passing in the region of VC/VS, thus stimulation may orthodromically and antidromically stimulate these tracts to modulate OFC, ACC, and thalamic activity (Rauch et al., [@B127]). ALIC stimulation may affect projections from OFC/subgenual ACC to thalamus running in the internal capsule or frontostriatal projections. Capsulotomy is thought to act by disrupting reciprocal projections between the OFC and MD thalamic nucleus that travel through the internal capsule; ALIC stimulation may act in a similar way. It has been hypothesized that the dysfunctional circuitry of OCD involves pathological positive feedback in these OFC-thalamic connections (Modell et al., [@B116]). DBS may act to dampen this hyperactivity and disrupt pathological signaling. Finally, as well as modulating activity in the structures and circuits targeted, DBS may affect neighboring structures and tracts. Relative location of DBS leads to particular fiber tracts may result in differential modulation of separate cortical subcortical circuits (Greenberg et al., [@B69]). This may have an important impact on differing clinical effects of DBS for OCD and may explain some of the discrepancies in functional imaging findings.

Conclusion {#s2}
==========

Accumulating evidence suggests that DBS is an effective therapy for treatment resistant OCD. Despite its efficacy, its mechanism remains poorly understood. As this treatment gains increasing acceptance and use more extensive studies in human and animal subjects may help to elucidate how DBS alters and remedies OCD pathology. DBS appears to alter activity in a number of regions with abnormal activity in OCD including OFC, ACC, and striatum, providing further evidence for the involvement of these regions in OCD pathology. Multiple effects of DBS on neural activity have been reported. DBS inhibits local neural firing while activating antidromic and orthodromic axonal conduction. It alters concentrations of excitatory and inhibitory neurotransmitters. It alters neural firing patterns, information transmission, and coherence between different regions. It may even affect neurogenesis. Ultimately, the mechanism of action behind the therapeutic effects of DBS in OCD is likely comprised of a complex combination of these effects.
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